Literature DB >> 35386736

Unusual type of scleromyxedema with multiple subcutaneous nodules, IgM-λ paraproteinemia, and scleroderma-like microangiopathy.

Kentaro Awaji1, Yoshihide Asano1, Mariko Takaoka1, Tomonori Oka1, Tomomi Miyake1, Hiraku Suga1, Shinichi Sato1.   

Abstract

Scleromyxedema is a mysterious cutaneous mucinosis of unknown etiology. Various types of scleromyxedema variant have been reported, which often give us a clue to understand the key aspects of this disease. Here, we describe a woman with highly unusual type of scleromyxedema. In addition to the rare manifestations of multiple subcutaneous nodules and IgM-λ paraproteinemia, our patient showed several characteristic symptoms of scleroderma such as shortened nails and fingertips, sclerodactyly, and bone resorption of fingertips and mandibles as a result of peripheral circulatory insufficiency, although this disease is known to be pathophysiologically different from scleroderma. A skin biopsy revealed cutaneous microvascular stenosis and occlusion due to intravascular mucin deposition and fibrotic changes, suggesting that scleromyxedema potentially develops peripheral circulatory disorders and other vascular involvement. The subcutaneous nodules were responsive to high-dose intravenous immunoglobulin. Scleromyxedema can represent a wide variety of systemic involvement, and therefore, we should pay attention to those symptoms as well as skin lesions.
© The Author(s) 2020.

Entities:  

Keywords:  IgM-λ paraproteinemia; Scleromyxedema; acroosteolysis; condylysis; microangiopathy; subcutaneous nodules

Year:  2020        PMID: 35386736      PMCID: PMC8892933          DOI: 10.1177/2397198320974190

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  9 in total

1.  European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.

Authors:  R Knobler; P Moinzadeh; N Hunzelmann; A Kreuter; A Cozzio; L Mouthon; M Cutolo; F Rongioletti; C P Denton; L Rudnicka; L A Frasin; V Smith; A Gabrielli; E Aberer; M Bagot; G Bali; J Bouaziz; A Braae Olesen; I Foeldvari; C Frances; A Jalili; U Just; V Kähäri; S Kárpáti; K Kofoed; D Krasowska; M Olszewska; C Orteu; J Panelius; A Parodi; A Petit; P Quaglino; A Ranki; J M Sanchez Schmidt; J Seneschal; A Skrok; M Sticherling; C Sunderkötter; A Taieb; A Tanew; P Wolf; M Worm; N J Wutte; T Krieg
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-08-08       Impact factor: 6.166

2.  Scleroderma renal crisis-like acute renal failure associated with mucopolysaccharide accumulation in renal vessels in a patient with scleromyxedema.

Authors:  Young H Lee; Joya Sahu; Marie S O'Brien; Vivette D D'Agati; Sergio A Jimenez
Journal:  J Clin Rheumatol       Date:  2011-09       Impact factor: 3.517

Review 3.  Scleromyxoedema with disseminated subcutaneous nodules: rare presentation of an uncommon dermatosis.

Authors:  S Singh; A J Kanwar; U N Saikia
Journal:  Clin Exp Dermatol       Date:  2012-05-21       Impact factor: 3.470

4.  Acroosteolysis in systemic sclerosis: An insight into hypoxia-related pathogenesis.

Authors:  Simon Siao-Pin; Laura-Otilia Damian; Laura Mirela Muntean; Simona Rednic
Journal:  Exp Ther Med       Date:  2016-10-05       Impact factor: 2.447

5.  Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.

Authors:  I Manousaridis; C Loeser; S Goerdt; J C Hassel
Journal:  Acta Dermatovenerol Alp Pannonica Adriat       Date:  2010-12

Review 6.  Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.

Authors:  Nelson Leung; Frank Bridoux; Colin A Hutchison; Samih H Nasr; Paul Cockwell; Jean-Paul Fermand; Angela Dispenzieri; Kevin W Song; Robert A Kyle
Journal:  Blood       Date:  2012-10-09       Impact factor: 22.113

7.  Occlusal and MRI characterizations in systemic sclerosis patients: A prospective study from Southern Italian cohort.

Authors:  Giovanni Matarese; Gaetano Isola; Angela Alibrandi; Alberto Lo Gullo; Gianluca Bagnato; Giancarlo Cordasco; Letizia Perillo
Journal:  Joint Bone Spine       Date:  2015-11-06       Impact factor: 4.929

8.  Scleromyxedema: clinical diagnosis and autopsy findings.

Authors:  Ana Carolina Bulhões Sala; Paulo Rowilson Cunha; Clóvis Antônio Lopes Pinto; Célia Antônia Xavier de Moraes Alves; Ingrid Barreto Paiva; Ana Paula Vieira Araujo
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

9.  Osteolysis Affecting the Jaws in Systemic Sclerosis: Clinical and Osseous Changes Based on a Case Presentation.

Authors:  A Delantoni; E Matziari
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2015-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.